Jpmorgan Chase & Co »

Purple Biotech shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Purple Biotech (PPBT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Purple Biotech

Tip: Access up to 7 years of quarterly data

All positions including Purple Biotech held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Purple Biotech by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $575 859 0.67
2023-09-30 $1.6k 1.4k 1.15

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Purple Biotech

Armistice Capital
Kingswood Wealth Advisors
Morgan Stanley
Citadel Advisors
XTX Topco
Millennium Management
Virtu Financial
Venture Visionary Partners
Wealth Advisors of Iowa
Geode Capital Management
UBS Group
Raymond James & Associates
TD Waterhouse Canada
Group One Trading
Royal Bank of Canada

View all funds holding Purple Biotech